The present invention provides trichloroethyl-sulfonylurea-containing compounds
that inhibit glycing transporters, pharmaceutical compositions comprising such
compounds, methods for using such compounds for inhibiting glycine transporters
and methods for using such compounds for the treatment of disease states in which
glycine is involved.